Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study
<p>Other than the influence of ionizing radiation and benign thyroid disease, little is known about the risk factors for differentiated thyroid cancer (TC) which is an increasing common cancer worldwide. Consistent evidence shows that body mass is positively associated with TC risk. As excess...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Wiley
2017
|
| _version_ | 1797076246421569536 |
|---|---|
| author | Dossus, L Franceschi, S Biessy, C Navionis, A-S Travis, R Weiderpass, E Scalbert, A Romieu, I Tjønneland, A Olsen, A Overvad, K Boutron-Ruault, M-C Bonnet, F Fournier, A Fortner, R Kaaks, R Aleksandrova, K Trichopoulou, A La Vecchia, C Peppa, E Turmino, R Panico, S Palli, D Agnoli, C Vineis, P Bueno-de-Mesquita, B Peeters, PH Skeie, G Zamora-Ros, R Chirlaque, M-D Ardanaz, E Sánchez, M-J Quíros, JR Dorronsoro, M Sandström, M Nilsson, LM Schmidt, JA Khaw, K-T Tsilidis, K Aune, Dagfinn Riboli, E Rinaldi, S |
| author_facet | Dossus, L Franceschi, S Biessy, C Navionis, A-S Travis, R Weiderpass, E Scalbert, A Romieu, I Tjønneland, A Olsen, A Overvad, K Boutron-Ruault, M-C Bonnet, F Fournier, A Fortner, R Kaaks, R Aleksandrova, K Trichopoulou, A La Vecchia, C Peppa, E Turmino, R Panico, S Palli, D Agnoli, C Vineis, P Bueno-de-Mesquita, B Peeters, PH Skeie, G Zamora-Ros, R Chirlaque, M-D Ardanaz, E Sánchez, M-J Quíros, JR Dorronsoro, M Sandström, M Nilsson, LM Schmidt, JA Khaw, K-T Tsilidis, K Aune, Dagfinn Riboli, E Rinaldi, S |
| author_sort | Dossus, L |
| collection | OXFORD |
| description | <p>Other than the influence of ionizing radiation and benign thyroid disease, little is known about the risk factors for differentiated thyroid cancer (TC) which is an increasing common cancer worldwide. Consistent evidence shows that body mass is positively associated with TC risk. As excess weight is a state of chronic inflammation, we investigated the relationship between concentrations of leptin, adiponectin, C-reactive protein, interleukin(IL)-6, IL-10 and TNF-α and the risk of TC.</p> <br/> <p>A case-control study was nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) study and included 475 first primary incident TC cases (399 women and 76 men) and 1,016 matched cancer-free cohort participants. Biomarkers were measured in serum samples using validated and highly sensitive commercially available immunoassays. Odds ratios (ORs) of TC by levels of each biomarker were estimated using conditional logistic regression models, adjusting for BMI and alcohol consumption. </p> <br/> <p>Adiponectin was inversely associated with TC risk among women (ORT3vs.T1=0.69, 95%CI: 0.49-0.98, Ptrend=0.04) but not among men (ORT3vs.T1=1.36, 95%CI: 0.67-2.76, Ptrend=0.37). Increasing levels of IL-10 were positively associated with TC risk in both genders and significantly so in women (ORT3vs.T1=1.59, 95%CI: 1.13-2.25, Ptrend=0.01) but not in men (ORT3vs.T1=1.78, 95%CI: 0.80-3.98, Ptrend=0.17). Leptin, CRP, IL-6 and TNF-α were not associated with TC risk in either gender.</p> <br/> <p>These results indicate a positive association of TC risk with IL-10 and a negative association with adiponectin that is probably restricted to women. Inflammation may play a role in TC in combination with or independently of excess weight. </p> |
| first_indexed | 2024-03-07T00:01:24Z |
| format | Journal article |
| id | oxford-uuid:76129e53-2d1b-42b2-884b-7772b5db4a8f |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:01:24Z |
| publishDate | 2017 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:76129e53-2d1b-42b2-884b-7772b5db4a8f2022-03-26T20:13:38ZAdipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:76129e53-2d1b-42b2-884b-7772b5db4a8fSymplectic Elements at OxfordWiley2017Dossus, LFranceschi, SBiessy, CNavionis, A-STravis, RWeiderpass, EScalbert, ARomieu, ITjønneland, AOlsen, AOvervad, KBoutron-Ruault, M-CBonnet, FFournier, AFortner, RKaaks, RAleksandrova, KTrichopoulou, ALa Vecchia, CPeppa, ETurmino, RPanico, SPalli, DAgnoli, CVineis, PBueno-de-Mesquita, BPeeters, PHSkeie, GZamora-Ros, RChirlaque, M-DArdanaz, ESánchez, M-JQuíros, JRDorronsoro, MSandström, MNilsson, LMSchmidt, JAKhaw, K-TTsilidis, KAune, DagfinnRiboli, ERinaldi, S<p>Other than the influence of ionizing radiation and benign thyroid disease, little is known about the risk factors for differentiated thyroid cancer (TC) which is an increasing common cancer worldwide. Consistent evidence shows that body mass is positively associated with TC risk. As excess weight is a state of chronic inflammation, we investigated the relationship between concentrations of leptin, adiponectin, C-reactive protein, interleukin(IL)-6, IL-10 and TNF-α and the risk of TC.</p> <br/> <p>A case-control study was nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) study and included 475 first primary incident TC cases (399 women and 76 men) and 1,016 matched cancer-free cohort participants. Biomarkers were measured in serum samples using validated and highly sensitive commercially available immunoassays. Odds ratios (ORs) of TC by levels of each biomarker were estimated using conditional logistic regression models, adjusting for BMI and alcohol consumption. </p> <br/> <p>Adiponectin was inversely associated with TC risk among women (ORT3vs.T1=0.69, 95%CI: 0.49-0.98, Ptrend=0.04) but not among men (ORT3vs.T1=1.36, 95%CI: 0.67-2.76, Ptrend=0.37). Increasing levels of IL-10 were positively associated with TC risk in both genders and significantly so in women (ORT3vs.T1=1.59, 95%CI: 1.13-2.25, Ptrend=0.01) but not in men (ORT3vs.T1=1.78, 95%CI: 0.80-3.98, Ptrend=0.17). Leptin, CRP, IL-6 and TNF-α were not associated with TC risk in either gender.</p> <br/> <p>These results indicate a positive association of TC risk with IL-10 and a negative association with adiponectin that is probably restricted to women. Inflammation may play a role in TC in combination with or independently of excess weight. </p> |
| spellingShingle | Dossus, L Franceschi, S Biessy, C Navionis, A-S Travis, R Weiderpass, E Scalbert, A Romieu, I Tjønneland, A Olsen, A Overvad, K Boutron-Ruault, M-C Bonnet, F Fournier, A Fortner, R Kaaks, R Aleksandrova, K Trichopoulou, A La Vecchia, C Peppa, E Turmino, R Panico, S Palli, D Agnoli, C Vineis, P Bueno-de-Mesquita, B Peeters, PH Skeie, G Zamora-Ros, R Chirlaque, M-D Ardanaz, E Sánchez, M-J Quíros, JR Dorronsoro, M Sandström, M Nilsson, LM Schmidt, JA Khaw, K-T Tsilidis, K Aune, Dagfinn Riboli, E Rinaldi, S Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title | Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title_full | Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title_fullStr | Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title_full_unstemmed | Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title_short | Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study |
| title_sort | adipokines and inflammation markers and risk of differentiated thyroid carcinoma the epic study |
| work_keys_str_mv | AT dossusl adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT franceschis adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT biessyc adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT navionisas adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT travisr adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT weiderpasse adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT scalberta adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT romieui adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT tjønnelanda adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT olsena adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT overvadk adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT boutronruaultmc adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT bonnetf adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT fourniera adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT fortnerr adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT kaaksr adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT aleksandrovak adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT trichopouloua adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT lavecchiac adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT peppae adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT turminor adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT panicos adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT pallid adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT agnolic adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT vineisp adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT buenodemesquitab adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT peetersph adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT skeieg adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT zamorarosr adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT chirlaquemd adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT ardanaze adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT sanchezmj adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT quirosjr adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT dorronsorom adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT sandstromm adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT nilssonlm adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT schmidtja adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT khawkt adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT tsilidisk adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT aunedagfinn adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT ribolie adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy AT rinaldis adipokinesandinflammationmarkersandriskofdifferentiatedthyroidcarcinomatheepicstudy |